Dr Reddy's Laboratories has deployed on-line clinical trails on new formulation products.
Currently, on-line trails are underway for Gatifloxacin (an antibiotic drug invented by Bristol Myers Squibb) and Zafirlukast (an anti-asthma product by Astra Zeneca) at various centers in Delhi, Bangalore, Chennai, Kolkatta and Hyderabad. These products are yet to be introduced in the Indian market, according to a Dr Reddy's spokesperson.
The on-line facility fastens clinical trails by six to eight weeks by using the Internet for electronic data-capturing and analysis from multiple trail centres.
Also Read
The application has features to ensure fast and better management of multi-centric trails and reduce the cost of interaction, the company said in a release.
The software and website application for clinical trails were conceived and designed by the company in collaboration with Quad-One Technologies, a city-based information technology company, the release added.
The application uses sophisticated tools to provide data output which can be directly used for statistical analysis, it said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
